Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Influence of Roux-en-Y gastric bypass on the hepatocellular function and bile flow of obese patients assessed by scintigraphy with DISIDA (2016)

  • Authors:
  • USP affiliated authors: NONINO, CARLA BARBOSA - FMRP ; SALGADO JÚNIOR, WILSON - FMRP ; SANTOS, JOSÉ SEBASTIÃO DOS - FMRP
  • USP Schools: FMRP; FMRP; FMRP
  • DOI: 10.1007/s11695-016-2176-2
  • Subjects: CIRURGIA BARIÁTRICA; CINTILOGRAFIA; BIÓPSIA; FÍGADO GORDUROSO
  • Keywords: Bariatric surgery; Nonalcoholic fatty liver disease; Hepatobiliary scintigraphy; Liver biopsy
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s11695-016-2176-2 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s11695-016-2176-2 (Fonte: Unpaywall API)

    Título do periódico: Obesity Surgery

    ISSN: 0960-8923,1708-0428



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Obesity Surgery

    ISSN: 0960-8923

    Citescore - 2017: 2.92

    SJR - 2017: 1.396

    SNIP - 2017: 1.219


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2847648pcd^2847648^Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SALGADO JÚNIOR, Wilson; DONADELLI, Carlos Augusto de Mattos; SANTOS, José Sebastião dos; NONINO, Carla Barbosa. Influence of Roux-en-Y gastric bypass on the hepatocellular function and bile flow of obese patients assessed by scintigraphy with DISIDA. Obesity Surgery, New York, v. 26, n. 11, p. 2718-2723, 2016. Disponível em: < http://dx.doi.org/10.1007/s11695-016-2176-2 > DOI: 10.1007/s11695-016-2176-2.
    • APA

      Salgado Júnior, W., Donadelli, C. A. de M., Santos, J. S. dos, & Nonino, C. B. (2016). Influence of Roux-en-Y gastric bypass on the hepatocellular function and bile flow of obese patients assessed by scintigraphy with DISIDA. Obesity Surgery, 26( 11), 2718-2723. doi:10.1007/s11695-016-2176-2
    • NLM

      Salgado Júnior W, Donadelli CA de M, Santos JS dos, Nonino CB. Influence of Roux-en-Y gastric bypass on the hepatocellular function and bile flow of obese patients assessed by scintigraphy with DISIDA [Internet]. Obesity Surgery. 2016 ; 26( 11): 2718-2723.Available from: http://dx.doi.org/10.1007/s11695-016-2176-2
    • Vancouver

      Salgado Júnior W, Donadelli CA de M, Santos JS dos, Nonino CB. Influence of Roux-en-Y gastric bypass on the hepatocellular function and bile flow of obese patients assessed by scintigraphy with DISIDA [Internet]. Obesity Surgery. 2016 ; 26( 11): 2718-2723.Available from: http://dx.doi.org/10.1007/s11695-016-2176-2

    Referências citadas na obra
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
    Suter M, Donadini A, Romy S, et al. Laparoscopic Roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg. 2011;254:267–73.
    Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143:722–8.
    Neuschwander-Tetri BA. Fatty liver and the metabolic syndrome. Curr Opin Gastroenterol. 2007;23:193–8.
    Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99–S112.
    Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis. 2007;11:191–207.
    Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord. 1998;22:222–6.
    Furuya Jr CK, de Oliveira CP, de Mello ES, et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol. 2007;22(4):510–4.
    Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396–402.
    Moretto M, Kupski C, da Silva VD, et al. Effect of bariatric surgery on liver fibrosis. Obes Surg. 2012;22(7):1044–9.
    Dowman JK, Tomlinson JW, Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2011;33(5):525–40.
    Mueller M, Kratzer W, Oeztuerk S, et al. Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years. BMC Gastroenterol. 2012;12:173.
    Masuda K, Ono M, Fukumoto M, et al. Usefulness of technetium-99 m-2-methoxy-isobutyl-isonitrile liver scintigraphy for evaluating disease activity of non-alcoholic fatty liver disease. Hepatol Res. 2012;42(3):273–9.
    Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.
    Colles SL, Dixon JB, Marks P, et al. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84(2):304–11.
    Tarnoff M, Kaplan LM, Shikora S. An evidence-based assessment of preoperative weight loss in bariatric surgery. Obes Surg. 2008;18(9):1059–61.
    Shimada M, Hashimoto E, Kaneda H, et al. Nonalcoholic steatohepatitis: risk factors for liver fibrosis. Hepatol Res. 2002;24(4):429–38.
    Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(23):7392–402.
    Dyson JK, Anstee QM, Mcpherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2014;5(3):211–8.
    Ma H, Patti ME. Bile acids, obesity and the metabolic syndrome. Best Practice & Research Clinical Gastroenterology. 2014;28:533–44.
    Penney NC, Kinross J, Newton RC, et al. The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. Int J Obes. 2015;39:1565–74.
    Glicksman C, Pournaras DJ, Wright M, et al. Postprandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem. 2010;47:482–4.
    Okuda H, Nunes R, Vallabhajosula S, et al. Studies of the hepatocellular uptake of the hepatobiliary scintiscanning agent 99mTc-DISIDA. J Hepatol. 1986;3(2):251–9.
    Kamisaka K, Gatmaitan Z, Moore CL, et al. Ligandin reverses bilirubin inhibition of liver mitochondrial respiration in vitro. Pediatr Res. 1975;9(12):903–5.
    Pizarro M, Balasubramaniyan N, Solís N, et al. Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function. Gut. 2004;53(12):1837–43.
    Esteller A. Physiology of bile secretion. World J Gastroenterol. 2008;14(37):5641–9.
    Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836–46.